Clicky

Bausch Health Companies Inc.(BHC) News

Date Title
Mar 28 The Enduring Losses Incurred by Carl Icahn’s 10 Activist Targets over the Long Term
Mar 28 Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?
Mar 25 All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy
Mar 21 BLCO or AVTR: Which Is the Better Value Stock Right Now?
Mar 20 Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock
Mar 15 Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term
Mar 6 Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
Mar 5 New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
Jan 18 CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
Jan 18 Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
Jan 8 Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
Jan 7 Bausch Health Companies Inc. (NYSE:BHC) is largely controlled by institutional shareholders who own 65% of the company
Dec 22 Bausch Health (BHC) Ulcerative Colitis Drug Meets Primary Goal
Dec 21 Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
Dec 18 Are Medical Stocks Lagging Bausch Health (BHC) This Year?
Dec 18 DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan
Dec 5 Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
Dec 1 Humana (HUM) Extends CINQCARE's Home Care Model to MA Members
Nov 30 Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?
Nov 29 5 Canadian stocks that have been complete disasters — and what investors can learn from them